Analyst Reco. LENZ Therapeutics, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 02:13:32 2024-05-14 pm EDT			5-day change	1st Jan Change
15.59 ^USD	-2.01%		-5.49%	0.00%

Apr. 15	Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target	MT
Apr. 15	William Blair Starts LENZ Therapeutics With Outperform Rating	MT

Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target	Apr. 15	MT
William Blair Starts LENZ Therapeutics With Outperform Rating	Apr. 15	MT
Piper Sandler Initiates LENZ Therapeutics at Overweight With $28 Price Target	Mar. 27	MT

No results for this search